Discoveries

Semisynthetic artemisinin anti-malarials reach African children

August 15, 2014

Scientist sitting with a group of children in Kenya

Jay Keasling with children in a village outside Nairobi, Kenya. (Photo by Gabrielle Tenenbaumn)

1.7million treatments of semisynthetic artemisinin have shipped to Africa, where they will treat malaria sufferers in Burkina Faso, Burundi, Democratic Republic of the Congo, Liberia, Niger and Nigeria over the next few months. This...

UC Berkeley Chemists and the Periodic Table

January 9, 2019

Seaborg, Ghiorso and other 104 discovery colleagues.

Photo: The Rutherfordium (element 104) discovery team in 1969: (l to r) Matti Nurmia, Jim Harris, Kari Eskola, Glen Seaborg, Pirkko Eskola and Albert Ghiorso.

Dimitri Mendeleev, a Russian chemist who in 1869 wrote out the known...

First natural enzyme creates azides from scratch

September 30, 2024
A team of researchers reported the discovery of the first natural enzyme capable of creating complex molecules, azides, from simpler molecules, which could lead to safer drug development and biological research.

New process vaporizes plastic bags and bottles, yielding gases to make new, recycled plastics

August 29, 2024
The catalytic process, discovered by researchers at UC Berkeley, efficiently reduces polymers to chemical precursors, bringing a circular economy for plastics one step closer to reality.

Meet our alumni: David Liu

March 29, 2023
Alumnus David Liu

Photo of David Liu via wikipedia. Uncredited.

"We can correct the vast majority of DNA errors that cause genetic diseases"

The Harvard University magazine published almost a couple of decades ago that one of its professors, the chemist...

David Schaffer: Research that takes risks must be supported

August 22, 2022

David Schaffer

Bakar Fellows Program Director and UC Berkeley professor David Schaffer reflects on the reasons why he sees Berkeley as a leader in world-changing research, innovation and entrepreneurship. (UC Berkeley photo by Mark Joseph Hanson)

The Berkeley Changemaker is a Berkeley News series highlighting innovative members of the campus community engaged in work and research that...

Berkeley startup aims to be a game changer in autoimmune disease therapy

July 22, 2021

 Geo Guillen, Marco Lobba, Matthew Francis
UC Berkeley business and chemistry alumni Geo Guillen, left, and Marco Lobba, middle, launched Catena Biosciences with Berkeley chemistry professor Matthew Francis. The trio credit Berkeley’s entrepreneurship ecosystem for their company’s rapid rise. (Photo courtesy of Catena Biosciences)

Marco Lobba was five years into his UC Berkeley chemistry Ph.D. program...

New $115 Million Quantum Systems Accelerator to Pioneer Quantum Technologies for Discovery Science

August 26, 2020

dilution refrigerator

The Quantum Systems Accelerator will optimize a wide range of advanced qubit technologies available today. Berkeley Lab uses sophisticated dilution refrigerators to cool and operate superconducting quantum processor circuits. (Credit: Thor Swift/Berkeley Lab)

The Department of Energy (DOE) has awarded $115 million over five years to the Quantum Systems Accelerator (QSA), a new...

Actinide acts as electron donor for first time

May 3, 2018

A new thorium-aluminum complex discovered A new thorium-aluminum complex is the first in which an actinide element donates electrons when bonding with a metal.

New CRISPR Center brings hope for rare and deadly genetic diseases

January 10, 2024
Jennifer Doudna and colleagues CRISPR collaboration combines expertise from three UC schools to scale treatment for diseases that industry has largely passed by – until now.